Manufacturer record
Ronald Pharmaceuticals (P) Ltd. B.No. 740-A: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Ronald Pharmaceuticals (P) Ltd. B.No. 740-A (Gujarat) was declared Not of Standard Quality in December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: RBMT-921, Ondansetron Tablets IP Anset Tablets (exp Aug 2028). CDTL, Mumbai (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. 2022 with respect to The test for Related substances. Listed in the December 2025 alert.
Records by type
1 record linked to Ronald Pharmaceuticals (P) Ltd. B.No. 740-A in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ondansetron Tablets IP Anset Tablets | Batch RBMT-921Mfg Sep 2025 · Exp Aug 2028 | The sample does not conform to I.P. 2022 with respect to The test for Related substances.Related substances | CDTL, MumbaiCDSCO lab | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.